Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease

1. Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease

   M. Yu. Nadinskaia, М. V. Maevskaya, В. Т. Ивашкин +9

   МақолаLiver Disease Diagnosis and TreatmentWorld Journal of Gastroenterology20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.000032

2. Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome

   Hao Zhang, Yiping Dang, Yuanjin Guo +8

   МақолаMedicinal plant effects and applicationsEuropean Journal of Pharmacology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.015269